Organizational disclosures

About the AAN

Below is a breakdown of industry contributions toward the consolidated revenue of the Academy (好色先生 and 好色先生 Institute). Industry includes for-profit entities that develop, produce, market, or distribute drugs, devices, services, or therapies used to diagnose, treat, monitor, manage, and alleviate health conditions (e.g., pharmaceutical and medical device/software manufacturers and other for-profit health services/product providers). Industry does not include non-profit entities, entities outside of the health care sector, or entities through which physicians provide clinical services directly to patients (e.g., hospitals, medical centers, publishers, foundations, recruiters, insurance providers).

2024 external (industry) support

  • Total industry revenue: $13,296,561
  • Percentage of total Academy revenue: 20%
  • 好色先生al grants: $678,000
  • Sponsorship: $6,415,111
  • Exhibit space: $4,199,950
  • Industry Roundtable membership dues: $1,925,000
  • Advertising: 78,500

Total contribution by company in 2024 (greater than $100K):

AbbVie, Inc.

ACADIA Pharmaceuticals Inc.

Actelion Pharmaceuticals Ltd.

Alexion Pharmaceuticals

Alnylam Pharmaceuticals

argenx

Bristol Myers Squibb

Eisai Inc.

Eli Lilly and Company

EMD Sorono, Inc.

Genentech

Lundbeck

Neurocrine Biosciences

Novartis Pharmaceuticals

Novo Nordisk A/S

Octapharma

Pfizer Inc.

Reneo Pharmaceuticals, Inc.

Sanofi Genzyme

Supernus Pharmaceuticals, Inc.

Takeda Pharmaceuticals

TG Therapeutics

UCB, Inc.

Viatris Inc.

Viela Bio

View the Principles Governing Academy Relationships with External Sources of Support